News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|February 25, 2011

CFP/CL Recommendation Widget

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

High-dose therapy boosts arm function in infants after perinatal stroke | Image credit: I-Acquire

High-dose therapy boosts arm function in infants after perinatal stroke

ByMorgan Ebert, Managing Editor

February 6th 2026

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children | Image Credit: birmingham.ac.uk.

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children

ByRenuka Dias, PhD, MBBS

February 6th 2026

FDA grants priority review to marstacimab for younger children and patients with hemophilia inhibitors

FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors

ByMorgan Ebert, Managing Editor

February 6th 2026

Parental concerns about disordered eating common in overweight children | Image Credit: © sosiukin - © sosiukin - stock.adobe.com.

Parental concerns about disordered eating common in overweight children

ByCeleste Krewson, Assistant Editor

February 6th 2026

Infant botulism outbreak linked to powdered formula under FDA investigation

Infant botulism outbreak linked to powdered formula under FDA investigation

ByMorgan Ebert, Managing Editor

February 5th 2026

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Trending on Contemporary Pediatrics

FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children

AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older

Infant botulism outbreak linked to powdered formula under FDA investigation

High-dose therapy boosts arm function in infants after perinatal stroke